This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2025
Areas of Expertise:
Title: Yeheng Zhu: Innovator in Pharmaceutical Compounds
Introduction
Yeheng Zhu is a distinguished inventor based in Stockton, NJ, who has contributed significantly to the field of pharmaceutical research. With an impressive portfolio of 18 patents, Zhu has focused his innovations on developing selective inhibitors that have the potential to transform treatment options for various medical conditions.
Latest Patents
Among his recent groundbreaking inventions are the Diazaspiro ROCK inhibitors. This invention encompasses compounds represented by Formula (I) and includes stereoisomers, tautomers, and pharmaceutically acceptable salts. These compounds are selective ROCK inhibitors, which are crucial for developing pharmaceutical compositions aimed at treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and inflammatory disorders.
Another notable patent developed by Zhu is the Pyrimidinones as factor XIa inhibitors. This patent provides compounds structured under Formula (1) that function as selective factor XIa inhibitors, as well as dual inhibitors of FXIa and plasma kallikrein. The associated pharmaceutical compositions focus on treating thromboembolic and inflammatory disorders effectively.
Career Highlights
Yeheng Zhu has worked with prominent companies, specifically Bristol-Myers Squibb, where he has enhanced the company's research capabilities. His extensive experience and innovative outlook have helped drive significant advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Zhu has collaborated with notable colleagues, including William R. Ewing and Andrew K. Dilger. These partnerships have fostered an environment of shared expertise and innovation, contributing to the successful development of transformative medical treatments.
Conclusion
In summary, Yeheng Zhu's contributions to pharmaceutical science through his inventions and patents mark him as a pivotal figure in the quest for innovative medical solutions. His work on selective inhibitors continues to pave the way for new treatments, showcasing the essential role of inventors like him in advancing healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile